Literature DB >> 3491189

Positron imaging of myocardial infarction with rubidium-82.

R A Goldstein, N A Mullani, W H Wong, R K Hartz, C H Hicks, F Fuentes, R W Smalling, K L Gould.   

Abstract

Positron imaging provides tomographic images of regional myocardial perfusion but has required an on-site cyclotron. Rubidium-82 (82Rb) is a short-lived (T1/2 = 75 sec) positron emitter available from a generator. In order to determine the feasibility for its use to image acute myocardial infarction, 18 patients with transmural infarctions who had coronary arteriography were given 30-40 mCi of 82Rb intravenously and positron tomographic imaging was carried out within 96 hr after onset of symptoms. Nine simultaneous transaxial slices were obtained for each patient with a positron camera. Images were also reconstructed in a long-axis, short-axis, and three-dimensional display. One study could not be interpreted because of excessive lung activity. Fourteen normals were also studied. The infarct related artery determined by angiography was correctly diagnosed by positron imaging in all 17 patients as were all three prior infarcts by readers blinded to the clinical data. No defects were observed in normals or in noninfarcted myocardial regions. This study indicates that 82Rb should be useful for perfusion imaging in patients with acute myocardial infarction. The short half-life of 82Rb should make it ideal for providing serial assessment of perfusion in patients undergoing thrombolytic therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491189

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  10 in total

1.  Viability assessment with MRI is superior to FDG-PET for viability: Con.

Authors:  Randolph E Patterson; Steven R Sigman; Robert E O'Donnell; Robert L Eisner
Journal:  J Nucl Cardiol       Date:  2010-04       Impact factor: 5.952

Review 2.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

3.  PET in clinical cardiology: can we already swim?

Authors:  J A Blokland; E K Pauwels; E E van der Wall
Journal:  Eur J Nucl Med       Date:  1990

4.  Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography.

Authors:  Y Tokuchi; H Isobe; H Takekawa; T Hanada; T Ishida; S Ogura; K Itoh; M Furudate; K Saito; Y Kawakami
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

5.  Experimental validation of a new quantitative method for the analysis of infarct size by cardiac perfusion tomography (SPECT).

Authors:  L Mortelmans; J Nuyts; J Vanhaecke; A Verbruggen; M De Roo; H De Geest; P Svetens; F Van de Werf
Journal:  Int J Card Imaging       Date:  1993-09

Review 6.  Clinical cardiac PET using generator-produced Rb-82: a review.

Authors:  K L Gould
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Sep-Oct       Impact factor: 2.740

Review 7.  Myocardial viability: what do we need?

Authors:  H Schoeder; M Friedrich; H Topp
Journal:  Eur J Nucl Med       Date:  1993-09

8.  Repeatability of regional myocardial blood flow calculation in 82Rb PET imaging.

Authors:  Karin Knešaurek; Josef Machac; Zhuangyu Zhang
Journal:  BMC Med Phys       Date:  2009-01-29

9.  Comparison of 18F SPECT with PET in myocardial imaging: a realistic thorax-cardiac phantom study.

Authors:  Karin Knešaurek; Josef Machac
Journal:  BMC Nucl Med       Date:  2006-10-31

Review 10.  Practical Implications of Myocardial Viability Studies.

Authors:  Wilter Dos Santos Ker; Thais Helena Peixoto Nunes; Marcelo Souto Nacif; Claudio Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2018-03       Impact factor: 2.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.